Skip to main content
SleepCited

Effects of L-cysteine, L-cysteine derivatives and ascorbic acid on lead excretion in rats.

E F McNiff, L K Cheng, H C Woodfield, H L Fung
Other Research communications in chemical pathology and pharmacology 1978
PubMed
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D663395'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
In Vitro
Population
animal model
Intervention
Effects of L-cysteine, L-cysteine derivatives and ascorbic acid on lead excretion in rats. None
Vergleichsgruppe
None
Primärer Endpunkt
kidney function
Wirkungsrichtung
Positive
Verzerrungsrisiko
Unclear

Abstract

Urinary and fecal excretion of lead in rats were compared after intravenous administration of L-cysteine and a number of its derivatives. In terms of increasing total lead excretion, L-cysteine ethyl ester was about half as effective as D-penicillamine, whereas L-cysteine and all other derivatives tested were only marginally effective. Interestingly, L-cysteine ethyl ester appeared to increase lead depletion mainly through biliary excretion. This compound may, therefore, have lower renal toxicity than other chelating agents which promote lead excretion principally by increasing urinary elimination. Dietary supplements containing 1% cysteine, 1% ascorbic acid of 1% of both substances did not dramatically increase lead elimination.

Used In Evidence Reviews

Similar Papers